Kamu erişimi zorunlu olan makaleler - Brendon L NeuenDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 3
Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial
SS Jain, J Yu, C Arnott, B Neal, V Perkovic, BL Neuen, M Jardine, ...
International Journal of Cardiology 395, 131444, 2024
Zorunlu olanlar: National Health and Medical Research Council, Australia, Medical Research …
Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
TY Milder, J Lin, SA Pearson, J de Oliveira Costa, BL Neuen, C Pollock, ...
Diabetes, Obesity and Metabolism 27 (2), 997-1000, 2025
Zorunlu olanlar: National Health and Medical Research Council, Australia, Wellcome Trust
Optimizing Clinical Outcomes Beyond Heart Failure With Intravenous Iron
BL Neuen, SV Badve, C Arnott
Journal of the American College of Cardiology 84 (18), 1718-1720, 2024
Zorunlu olanlar: National Health and Medical Research Council, Australia
Bir yerde sunuluyor: 74
Chronic kidney disease
K Kalantar-Zadeh, TH Jafar, D Nitsch, BL Neuen, V Perkovic
The Lancet, 2021
Zorunlu olanlar: US National Institutes of Health, National Medical Research Council, Singapore
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
BL Neuen, T Young, HJL Heerspink, B Neal, V Perkovic, L Billot, ...
The lancet Diabetes & endocrinology 7 (11), 845-854, 2019
Zorunlu olanlar: National Health and Medical Research Council, Australia, Medical Research …
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
TNDPHRSG the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists Consortium
The Lancet 400 (10365), 1788-1801, 2022
Zorunlu olanlar: US National Institutes of Health, British Heart Foundation, UK Medical …
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta‐analysis
T Toyama, BL Neuen, M Jun, T Ohkuma, B Neal, MJ Jardine, ...
Diabetes, Obesity and Metabolism 21 (5), 1237-1250, 2019
Zorunlu olanlar: National Health and Medical Research Council, Australia, Medical Research …
Sodium‐glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis
C Arnott, Q Li, A Kang, BL Neuen, S Bompoint, CSP Lam, A Rodgers, ...
Journal of the American Heart Association 9 (3), e014908, 2020
Zorunlu olanlar: National Health and Medical Research Council, Australia, Medical Research …
Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials
BL Neuen, M Oshima, R Agarwal, C Arnott, DZ Cherney, R Edwards, ...
Circulation 145 (19), 1460-1470, 2022
Zorunlu olanlar: US National Institutes of Health
Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis
JT Ha, BL Neuen, LP Cheng, M Jun, T Toyama, MP Gallagher, MJ Jardine, ...
Annals of internal medicine 171 (3), 181-189, 2019
Zorunlu olanlar: National Health and Medical Research Council, Australia, Medical Research …
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
BL Neuen, M Oshima, V Perkovic, R Agarwal, C Arnott, G Bakris, ...
European heart journal 42 (48), 4891-4901, 2021
Zorunlu olanlar: US National Institutes of Health, National Health and Medical Research …
Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with …
BL Neuen, HJL Heerspink, P Vart, BL Claggett, RA Fletcher, C Arnott, ...
Circulation 149 (6), 450-462, 2024
Zorunlu olanlar: US National Institutes of Health
Peritoneal dialysis use and practice patterns: an international survey study
Y Cho, AK Bello, A Levin, M Lunney, MA Osman, F Ye, GE Ashuntantang, ...
American Journal of Kidney Diseases 77 (3), 315-325, 2021
Zorunlu olanlar: National Health and Medical Research Council, Australia
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
M Oshima, BL Neuen, MJ Jardine, G Bakris, R Edwards, A Levin, ...
The Lancet Diabetes & Endocrinology 8 (11), 903-914, 2020
Zorunlu olanlar: National Health and Medical Research Council, Australia, Netherlands …
Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes
JW Li, B Neal, V Perkovic, D de Zeeuw, BL Neuen, C Arnott, R Simpson, ...
Kidney international 98 (3), 769-777, 2020
Zorunlu olanlar: US National Institutes of Health, National Health and Medical Research …
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
LA Inker, W Collier, T Greene, S Miao, J Chaudhari, GB Appel, SV Badve, ...
Nature medicine 29 (7), 1867-1876, 2023
Zorunlu olanlar: US Department of Defense, US National Institutes of Health, National Health …
Predictors of patency after balloon angioplasty in hemodialysis fistulas: a systematic review
BL Neuen, R Gunnarsson, AC Webster, RA Baer, J Golledge, ML Mantha
Journal of Vascular and Interventional Radiology 25 (6), 917-924, 2014
Zorunlu olanlar: National Health and Medical Research Council, Australia
Hemodialysis use and practice patterns: an international survey study
H Htay, AK Bello, A Levin, M Lunney, MA Osman, F Ye, GE Ashuntantang, ...
American Journal of Kidney Diseases 77 (3), 326-335. e1, 2021
Zorunlu olanlar: National Health and Medical Research Council, Australia, Canadian Institutes …
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial
T Sen, J Li, BL Neuen, B Neal, C Arnott, CR Parikh, SG Coca, V Perkovic, ...
Diabetologia 64 (10), 2147-2158, 2021
Zorunlu olanlar: US National Institutes of Health, National Health and Medical Research …
Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes
BL Neuen, C Arnott, V Perkovic, G Figtree, D de Zeeuw, G Fulcher, M Jun, ...
Diabetes, Obesity and Metabolism 23 (2), 382-390, 2021
Zorunlu olanlar: US National Institutes of Health, National Health and Medical Research …
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir